HeartSciences (HSCSW) Accumulated Depreciation & Amortization (2022 - 2026)
HeartSciences posted quarterly Accumulated Depreciation & Amortization of $558391.0 for Q1 2026, up 5.39% year-on-year from $529845.0 in Q1 2025, and up 1.25% on a QoQ basis from $551475.0 in Q4 2025.
HeartSciences (HSCSW) has 5 years of Accumulated Depreciation & Amortization data on file, last reported at $558391.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 5.39% year-over-year to $558391.0; the trailing twelve-month figure through Jan 2026 stood at $558391.0 (up 5.39% YoY), and the FY2025 full-year result was $537358.0, up 7.52% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $558391.0, up from $551475.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $558391.0 in Q1 2026 and bottomed at $444952.0 in Q2 2022.
- The 5-year median for Accumulated Depreciation & Amortization is $495158.5 (2024), against an average of $500297.8.
- Peak annual rise in Accumulated Depreciation & Amortization reached 8.01% in 2025, while the deepest fall reached 5.28% in 2025.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $458177.0 in 2022, then grew by 6.26% to $486841.0 in 2023, then grew by 7.6% to $523838.0 in 2024, then increased by 5.28% to $551475.0 in 2025, then increased by 1.25% to $558391.0 in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $558391.0 (Q1 2026), $551475.0 (Q4 2025), and $544469.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | HeartSciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 558,391.00 |
| Jan 31, 2026 | 558,391.00 |
| Oct 31, 2025 | 551,475.00 |
| Oct 31, 2025 | 551,475.00 |
| Jul 31, 2025 | 544,469.00 |
| Jul 31, 2025 | 544,469.00 |
| Apr 30, 2025 | 537,358.00 |
| Apr 30, 2025 | 537,358.00 |
| Jan 31, 2025 | 529,845.00 |
| Jan 31, 2025 | 529,845.00 |
| Oct 31, 2024 | 523,838.00 |
| Oct 31, 2024 | 523,838.00 |
| Jul 31, 2024 | 511,623.00 |
| Jul 31, 2024 | 511,623.00 |
| Apr 30, 2024 | 499,759.00 |
| Apr 30, 2024 | 499,759.00 |
| Jan 31, 2024 | 490,558.00 |
| Jan 31, 2024 | 490,558.00 |
| Oct 31, 2023 | 486,841.00 |
| Oct 31, 2023 | 486,841.00 |
| Jul 31, 2023 | 479,205.00 |
| Jul 31, 2023 | 479,205.00 |
| Apr 30, 2023 | 471,867.00 |
| Apr 30, 2023 | 471,867.00 |
| Jan 31, 2023 | 465,042.00 |
| Jan 31, 2023 | 465,042.00 |
| Oct 31, 2022 | 458,177.00 |
| Oct 31, 2022 | 458,177.00 |
| Jul 31, 2022 | 451,364.00 |
| Jul 31, 2022 | 451,364.00 |
| Apr 30, 2022 | 444,952.00 |
| Apr 30, 2022 | 444,952.00 |